Abstract
This study aimed to identify independent risk factors for first occurrence of stroke in Chinese individuals based on prospective cohort studies. Forty prospective cohort studies assessing 1,984,552 individuals were selected for the final meta-analysis. The identified risk factors for stroke in the Chinese population included old age (RR = 1.86, 95%CI: 1.47–2.36), hypertension (RR = 2.76, 95%CI: 2.26–3.37), cardiovascular disease history (RR = 1.98, 95%CI: 1.06–3.69), chronic kidney disease (RR = 1.65, 95%CI: 1.36–2.01), diabetes mellitus (RR = 1.71, 95%CI: 1.34–2.18), metabolic syndrome (RR = 1.59, 95%CI: 1.33–1.90), hyperglycemia (RR = 1.49, 95% CI: 1.31–1.69), obesity (RR = 1.45, 95%CI: 1.29–1.63), smoking (RR = 1.42, 95% CI: 1.27–1.58), prolonged sleep time (> 7.5 h, RR = 1.44, 95%CI: 1.19–1.75), higher levels of triglyceride (RR = 1.19, 95%CI: 1.07-1.32), C-reactive protein (RR = 1.34, 95%CI: 1.07-1.69). High fruit-rich diet (RR = 0.68, 95%CI: 0.58-0.80) was associated with a lower risk of stroke. The spectrum and power of risk factors varied among different cohort inclusion years. These findings provide a comprehensive tool for the primary prevention of stroke in Chinese individuals.
Introduction
Stroke is considered the second most common cause of death and disability-adjusted life years (DALYs) among adults aged 50 years or over, according to the Global Burden of Disease Study 2019 (1). There are estimated 7.74 and 4.19 million incident cases of acute first ischemic stroke (IS) and hemorrhagic stroke (HS) worldwide, respectively (2). Studies have indicated that stroke development could be affected by several modifiable risk factors, including elevated lipid profiles, blood pressure (BP), diabetes mellitus (DM), smoking, alcohol, obesity, unhealthy diet, psycho-social stress, and lack of physical activity (PA) (3–5). Via risk factor management including lifestyle intervention (e.g., smoking cessation) and pharmacological intervention (e.g., blood pressure-lowering medication), the age-standardized incidence of stroke has declined by 8.1% globally from 1990 to 2016, and by 20.3% in countries with high Socio-demographic index. In China, stroke is comparatively much less well-controlled, with the age-standardized incidence of stroke increasing by 5.4% from 1990 to 2016 (6). The prevalence of HS is remarkably higher in China compared with other countries (2). A previous systematic review reported HS prevalence in Chinese individuals is two-fold that of Caucasians (7). Therefore, vigorous and efficient primary preventive actions are urgently in need. Unfortunately, the comprehensive profile of risk factors for stroke in the Chinese population still remains undefined up to now.
In the current study, we performed a meta-analysis of prospective cohort studies in Chinese individuals to identify potential risk factors for first occurrence of stroke. Stratified analyses based on types of stroke were also carried out in this study.
Methods
Data Sources, Search Strategy, and Selection Criteria
This comprehensive quantitative meta-analysis was carried out and reported, following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Statement (8). Studies that were designed as prospective cohort trials and reported effect estimates of the risk of first stroke occurrence in Chinese population were included in this study, with no restriction on publication status. On August 22, 2020, we searched the PubMed, EmBase, and Cochrane library databases with the following core search terms: “stroke” AND “risk factors” AND “Chinese.” The details of the search strategy are presented in Supplemental 1. We restricted the publication language to English. To further identify studies which are potentially eligible, a manual search of retrieved articles was conducted in addition.
The initial study selection by reviewing titles and abstracts was conducted by two authors independently, followed by the full-text evaluation based on group discussion involving 3 authors independently. Any disagreement among the authors was settled by the corresponding author after reviewing the original articles. Studies satisfying the following inclusion criteria were included in the meta-analysis: (1) prospective cohort design; (2) assessed risk factors including demographic features, pre-existing diseases, lifestyles, and biochemical exposures reported in ≥ 3 studies; (3) reported original data or adjusted effect estimates (odds ratio [OR], relative risk [RR], or hazard ratio [HR]) with 95% confidence interval (CI); (4) inclusion of healthy Chinese individuals aged ≥18.0 years without stroke history.
Data Collection and Quality Assessment
Data extraction and quality assessment were carried out by 2 authors. Any disagreement among the authors was settled by an additional author reviewing the original articles. The extracted data were entered in a standardized data collection form. The collected items included name of the first author or the whole study group, publication year, sample size, mean participant age, number of men/women, follow-up duration, reported outcomes, adjusted factors, and effect estimates of the risk of stroke. The Newcastle-Ottawa Scale (NOS), a comprehensive tool and partially validated method for assessing the quality of observational studies (9), was used to assess the quality of included studies. The “star system” of NOS, including selection, comparison and outcome, ranged from 0 to 9. A study with 7 or more stars was considered of high quality.
Statistical Analysis
The profile of risk factors for first occurrence of stroke in Chinese individuals was examined as binary data. Given the low incidence of stroke, the OR could be regarded as equal to the RR. Moreover, the HR was considered to be approximately equal to RR because the included studies were designed as prospective cohort trials. Then, the pooled RR was calculated by a random-effects model for each parameter (10). Heterogeneity across the included studies for each risk factor was assessed by the I2 index and Q statistic; significant heterogeneity was considered with a P-value for Q statistic <0.10 (11). Sensitivity analysis was carried out for factors reported in ≥ 10 cohorts by sequentially excluding individual studies (12). Regression analysis was employed to assess the role of cohort inclusion years in the risk of stroke if the factor was reported in ≥ 5 cohorts. Subgroup analysis was also conducted according to types of stroke and cohort inclusion years (inclusion year before 2000 vs. after 2000), while the interaction P-value was calculated to assess the differences between subgroups (13). Publication bias for factors reported in ≥ 10 cohorts was also evaluated using funnel plots, and the Egger and Begg tests (14). The P-value for all pooled results was two-sided, and P < 0.05 was considered statistically significant. The STATA software (version 10.0; Stata Corporation, College Station, TX, USA) was employed for data analysis.
Results
Literature Search
The initial electronic search yielded 21,109 articles, and 14,461 were excluded owing to duplicate titles. The remaining 6,648 articles were reviewed by titles and abstracts, and 6,147 were further excluded due to topic irrelevance. A total of 501 studies were retrieved for full-text evaluation, and 40 cohorts reported in 89 studies assessing 1,984,552 individuals were selected for final quantitative meta-analysis. A further manual search throughout the reference lists of included studies yielded no more eligible studies. Details concerning literature search and the study selection process are shown in Figure 1.
Figure 1
The PRISMA flowchart for literature search and study selection.
Study Characteristics
Supplemental 2 summarizes the baseline characteristics of included studies and examined populations. The included studies were published in 1996–2019, and each included 421-489,301 individuals. The follow-up duration ranged from 1.0 to 30.0 years. Three of the included cohorts reported unadjusted effect estimates, and the remaining 37 reported adjusted effect estimates. The quality of included studies was assessed by the NOS. Eight studies had 8 stars, 21 had 7 stars, and the remaining 11 had 6 stars.
Meta-Analysis
The pooled results for stroke risk factor profiles are summarized in Figure 2 and Table 1.
Figure 2
Summary risk factors for stroke incidence.
Table 1
| Outcomes | Number of cohorts | RR and 95%CI | P-value | Heterogeneity (%) | P-value for heterogeneity |
|---|---|---|---|---|---|
| Demographic | |||||
| Elderly | 5 | 1.86 (1.47–2.36) | <0.001 | 42.0 | 0.111 |
| Sex (female vs. male) | 5 | 0.85 (0.66–1.09) | 0.191 | 72.5 | 0.003 |
| Pre-existing diseases | |||||
| Hypertension | 19 | 2.76 (2.26–3.37) | <0.001 | 95.8 | <0.001 |
| CVD history | 4 | 1.98 (1.06–3.69) | 0.033 | 83.7 | <0.001 |
| CKD | 6 | 1.65 (1.36–2.01) | <0.001 | 47.7 | 0.046 |
| DM | 7 | 1.71 (1.34–2.18) | <0.001 | 63.3 | 0.012 |
| Metabolic Syndrome | 6 | 1.59 (1.33–1.90) | <0.001 | 22.7 | 0.249 |
| Hyperglycemia | 7 | 1.49 (1.31–1.69) | <0.001 | 0.0 | 0.531 |
| Obesity | 15 | 1.45 (1.29–1.63) | <0.001 | 74.3 | <0.001 |
| Life style | |||||
| Smoking | 15 | 1.42 (1.27–1.58) | <0.001 | 78.0 | <0.001 |
| Alcohol | 5 | 1.07 (0.82–1.40) | 0.626 | 77.8 | 0.001 |
| Sleep time (> 7.5 h) | 4 | 1.44 (1.19–1.75) | <0.001 | 76.7 | <0.001 |
| Sleep time (<6.5 h) | 4 | 1.01 (0.90–1.13) | 0.917 | 44.0 | 0.098 |
| Sleep behavior disorder | 3 | 1.73 (0.83–3.61) | 0.146 | 84.4 | 0.002 |
| Fruit-Rich Diet | 3 | 0.68 (0.58–0.80) | <0.001 | 69.9 | 0.036 |
| Biochemical exposures | |||||
| TC | 4 | 1.05 (0.98–1.13) | 0.151 | 35.4 | 0.158 |
| TG | 6 | 1.19 (1.07–1.32) | 0.001 | 67.0 | 0.002 |
| LDL | 3 | 1.09 (0.85–1.39) | 0.502 | 75.6 | 0.003 |
| HDL | 6 | 0.90 (0.81–1.00) | 0.062 | 77.8 | <0.001 |
| Hypertriglyceridemia | 3 | 1.33 (0.79–2.21) | 0.280 | 78.3 | 0.010 |
| CRP | 3 | 1.34 (1.07-1.69) | 0.012 | 25.3 | 0.262 |
| Uric acid | 3 | 1.11 (0.83–1.47) | 0.490 | 67.7 | 0.045 |
The summary results for risk factors.
The summary RRs indicated elderly (RR = 1.86, 95%CI: 1.47–2.36, P < 0.001) was associated with increased risk of stroke, whereas no sex difference was found regarding the risk of stroke (RR = 0.85, 95%CI: 0.66–1.09, P = 0.191). Pre-existing hypertension (RR = 2.76, 95%CI: 2.26–3.37; P < 0.001), cardiovascular disease (CVD) history (RR = 1.98, 95%CI: 1.06–3.69; P = 0.033), chronic kidney disease (CKD) (RR = 1.65, 95%CI: 1.36–2.01, P < 0.001), diabetes mellitus (DM) (RR = 1.71, 95%CI: 1.34–2.18, P < 0.001), metabolic syndrome (RR = 1.59, 95% CI: 1.33–1.90, P < 0.001), hyperglycemia (RR = 1.49, 95% CI: 1.31–1.69, P < 0.001) and obesity (RR = 1.45, 95%CI: 1.29–1.63, P < 0.001) were associated with increased risk of stroke. Unhealthy lifestyles, including smoking (RR = 1.42, 95%CI: 1.27–1.58, P < 0.001) and prolonged sleep time (>7.5 h) (RR = 1.44, 95%CI: 1.19–1.75, P < 0.001), increased the risk of stroke. Meanwhile, alcohol intake, short sleep time (<6.5 h), and sleep behavior disorder were not associated with the risk of stroke. Besides, higher fruit-rich diet intake led to a reduced risk of stroke (RR = 0.68, 95%CI: 0.58–0.80, P < 0.001). In addition, higher levels of triglycerides (TG) (RR = 1.19, 95%CI: 1.07–1.32, P = 0.001) and C-reactive protein (CRP) (RR = 1.34, 95%CI: 1.07–1.69, P = 0.012) were associated with increased risk of stroke, whereas TC, LDL, HDL, hypertriglyceridemia, and uric acid were not associated with the risk of stroke in the Chinese population. Significant heterogeneity was observed for sex (I2= 72.5%; P = 0.003), hypertension (I2= 95.8%; P < 0.001), CVD history (I2= 83.7%; P < 0.001), CKD (I2= 47.7%; P = 0.046), DM (I2= 63.3%; P = 0.012), obesity (I2= 74.3%; P < 0.001), smoking (I2= 78.0%; P < 0.001), alcohol intake (I2= 77.8%; P = 0.001), prolonged sleep time (>7.5 h) (I2= 76.7%; P < 0.001), short sleep time (<6.5 h) (I2= 44.0%; P = 0.098), sleep behavior disorder (I2= 84.4%; P = 0.002), fruit-rich diet (I2= 69.9%; P = 0.036), TG (I2= 67.0%; P = 0.002), LDL (I2= 75.6%; P = 0.003), HDL (I2= 77.8%; P < 0.001), hypertriglyceridemia (I2= 78.3%; P = 0.010), and uric acid (I2= 67.7%; P = 0.045). No other significant heterogeneity across the included studies was observed. The associations of hypertension, obesity, and smoking with the risk of stroke in Chinese individuals were reported in ≥ 10 cohorts, and sensitivity analysis suggested that the pooled conclusions were robust irrespective of excluded studies (Supplemental 3).
Subgroup Analysis
Subgroup analysis (Table 2) suggested that hypertension, CVD history, CKD, hyperglycemia and obesity were associated with the risk of both IS and HS. The RRs of hypertension and sleep behavior disorder were high in HS, while that of obesity was high in IS. Subgroup analysis also showed that DM, metabolic syndrome, smoking, prolonged sleep time (>7.5 h), and elevated TC, TG, and CRP were only associated with the risk of IS. Alcohol intake was only associated with a reduced risk of IS, while not significantly affecting the risk of HS. A fruit-rich diet could protect the body against both IS and HS risk, and the protective effect was stronger on HS than on IS.
Table 2
| Factor | Subgroup | Number of studies | RR and 95%CI | P-value | Heterogeneity | P-value between subgroups |
|---|---|---|---|---|---|---|
| Sex (female vs. male) | IS | 4 | 0.93 (0.57–1.51) | 0.769 | 83.8 (<0.001) | 0.376 |
| HS | 2 | 0.70 (0.53–0.91) | 0.008 | 53.4 (0.143) | ||
| Hypertension | IS | 12 | 2.36 (1.93–2.89) | <0.001 | 72.5 (<0.001) | <0.001 |
| HS | 6 | 3.67 (2.28–5.92) | <0.001 | 89.3 (<0.001) | ||
| CVD history | IS | 2 | 2.21 (1.25–3.91) | 0.006 | 5.4 (0.304) | 0.422 |
| HS | 1 | 2.82 (2.07–3.85) | <0.001 | - | ||
| CKD | IS | 9 | 1.57 (1.24–1.99) | <0.001 | 50.4 (0.041) | 0.106 |
| HS | 2 | 2.25 (1.52–3.35) | <0.001 | 0.0 (0.751) | ||
| DM | IS | 2 | 1.92 (1.51–2.45) | <0.001 | 35.7 (0.212) | 0.005 |
| HS | 2 | 1.27 (0.89–1.81) | 0.180 | 64.2 (0.095) | ||
| Metabolic Syndrome | IS | 4 | 1.72 (1.24–2.38) | 0.001 | 61.0 (0.053) | 0.361 |
| HS | 2 | 1.36 (0.99–1.88) | 0.057 | 0.0 (0.650) | ||
| Hyperglycemia | IS | 5 | 1.45 (1.13–1.85) | 0.003 | 30.2 (0.220) | 0.904 |
| HS | 4 | 1.45 (1.20–1.77) | <0.001 | 0.0 (0.604) | ||
| Obesity | IS | 13 | 1.73 (1.51–1.98) | <0.001 | 69.6 (<0.001) | <0.001 |
| HS | 11 | 1.31 (1.08–1.58) | 0.005 | 66.0 (0.001) | ||
| Smoking | IS | 10 | 1.63 (1.46–1.83) | <0.001 | 0.0 (0.500) | 0.060 |
| HS | 6 | 1.18 (0.85–1.63) | 0.318 | 67.6 (0.009) | ||
| Alcohol | IS | 1 | 0.76 (0.63–0.92) | 0.004 | - | 0.326 |
| HS | 1 | 0.92 (0.66–1.28) | 0.622 | - | ||
| Sleep time (> 7.5 hours) | IS | 3 | 1.32 (1.02–1.70) | 0.035 | 76.8 (0.013) | 0.202 |
| HS | 3 | 1.15 (0.87–1.52) | 0.329 | 36.5 (0.207) | ||
| Sleep time (<6.5 hours) | IS | 3 | 1.07 (0.84–1.37) | 0.563 | 82.6 (0.003) | 0.575 |
| HS | 3 | 0.97 (0.81–1.17) | 0.776 | 0.0 (0.734) | ||
| Sleep behavior disorder | IS | 1 | 1.93 (1.07–3.47) | 0.028 | - | 0.048 |
| HS | 1 | 6.61 (2.27–19.26) | 0.001 | - | ||
| Fruit-rich diet | IS | 1 | 0.75 (0.72–0.79) | <0.001 | - | 0.034 |
| HS | 1 | 0.64 (0.56–0.74) | <0.001 | - | ||
| TC | IS | 4 | 1.13 (1.04–1.23) | 0.005 | 30.7 (0.217) | 0.001 |
| HS | 3 | 0.93 (0.84–1.02) | 0.119 | 2.9 (0.378) | ||
| TG | IS | 4 | 1.20 (1.05–1.38) | 0.010 | 67.6 (0.015) | 0.525 |
| HS | 3 | 1.13 (0.95–1.36) | 0.164 | 64.0 (0.040) | ||
| LDL | IS | 2 | 1.42 (0.84–2.38) | 0.190 | 89.0 (0.003) | 0.019 |
| HS | 3 | 0.92 (0.77–1.10) | 0.339 | 0.0 (0.418) | ||
| HDL | IS | 4 | 0.95 (0.90–1.01) | 0.108 | 0.0 (0.702) | 0.001 |
| HS | 3 | 0.89 (0.72–1.10) | 0.285 | 87.4 (<0.001) | ||
| Hypertriglyceridemia | IS | 1 | 1.36 (0.98–1.89) | 0.066 | - | 0.371 |
| HS | 2 | 1.21 (0.40–3.65) | 0.734 | 88.1 (0.004) | ||
| CRP | IS | 2 | 1.31 (1.10–1.57) | 0.003 | 0.0 (0.419) | 0.227 |
| HS | 2 | 1.05 (0.77–1.44) | 0.738 | 0.0 (0.449) | ||
| Uric acid | IS | 2 | 1.13 (0.80–1.60) | 0.475 | 70.2 (0.067) | 0.495 |
| HS | 2 | 0.93 (0.54–1.61) | 0.791 | 64.8 (0.092) |
Subgroup analysis of stroke subtypes.
Stratified analyses based on cohort inclusion years were also conducted, and cohort inclusion years could bias the associations of sex (female vs. male), hypertension, DM, obesity, smoking, and elevated TG and HDL with the risk of stroke (Table 3). In pooled cohorts initially recruited before 2000, hypertension, CKD, DM, hyperglycemia, obesity, and smoking were associated with increased risk of stroke. Furthermore, in pooled cohorts initially recruited in 2000 or afterwards, hypertension, DM, metabolic syndrome, hyperglycemia, smoking, and elevated TG were associated with increased risk of stroke. Finally, the female sex and elevated HDL decreased the risk of stroke when pooled cohorts were initially recruited in or after 2000.
Table 3
| Factor | Inclusion period | RR and 95%CI | P-value | Heterogeneity (%) | P-value for heterogeneity | P-value between subgroups |
|---|---|---|---|---|---|---|
| Sex (female vs. male) | 2000 or after | 0.64 (0.56–0.73) | <0.001 | 0.0 | 0.650 | <0.001 |
| Before 2000 | 1.06 (0.82–1.37) | 0.658 | 21.6 | 0.281 | ||
| Hypertension | 2000 or after | 2.33 (1.82–2.96) | <0.001 | 71.6 | <0.001 | <0.001 |
| Before 2000 | 3.04 (2.32–3.98) | <0.001 | 97.2 | <0.001 | ||
| CKD | 2000 or after | 1.36 (0.77–2.40) | 0.282 | 77.2 | 0.004 | 0.312 |
| Before 2000 | 1.79 (1.51–2.12) | <0.001 | 0.0 | 0.695 | ||
| DM | 2000 or after | 1.44 (1.20–1.73) | <0.001 | 27.6 | 0.246 | 0.001 |
| Before 2000 | 2.53 (1.91–3.34) | <0.001 | 0.0 | 0.620 | ||
| Metabolic Syndrome | 2000 or after | 1.62 (1.37–1.92) | <0.001 | 0.0 | 0.749 | 0.549 |
| Before 2000 | 2.05 (0.88–4.76) | 0.096 | 70.4 | 0.034 | ||
| Hyperglycemia | 2000 or after | 1.48 (1.27–1.71) | <0.001 | 1.6 | 0.406 | 0.858 |
| Before 2000 | 1.52 (1.19–1.93) | 0.001 | 0.0 | 0.404 | ||
| Obesity | 2000 or after | 1.26 (0.97–1.63) | 0.077 | 85.1 | <0.001 | 0.037 |
| Before 2000 | 1.51 (1.30–1.76) | <0.001 | 54.0 | 0.026 | ||
| Smoker | 2000 or after | 1.46 (1.27–1.67) | <0.001 | 0.0 | 0.321 | 0.014 |
| Before 2000 | 1.40 (1.24–1.58) | <0.001 | 80.0 | <0.001 | ||
| TG | 2000 or after | 1.50 (1.28–1.77) | <0.001 | 0.0 | 0.959 | <0.001 |
| Before 2000 | 1.09 (1.00–1.18) | 0.052 | 47.8 | 0.088 | ||
| HDL | 2000 or after | 0.82 (0.69–0.97) | 0.022 | 52.3 | 0.123 | <0.001 |
| Before 2000 | 0.96 (0.91–1.01) | 0.146 | 0.0 | 0.423 |
Subgroup analysis of stroke incidence based on inclusion period.
Next, the potential role of cohort inclusion years in pooled effect estimates was investigated for factors reported in ≥5 cohorts (Supplemental 4). The results showed that the cumulative RRs of hypertension (P = 0.020) and obesity (P = 0.046) in HS decreased with increasing inclusion years. However, no association was observed between cohort inclusion years and the effects of alcohol, CKD, DM, sex, hyperglycemia, hypertension, metabolic syndrome, obesity, and smoking on the risk of all types of stroke. Furthermore, the associations of CKD, hypertension, obesity, and smoking with the risk of IS were not affected by cohort inclusion years. Finally, cohort inclusion years did not affect the association between smoking and the risk of HS.
Publication Bias
Publication bias was evaluated for hypertension, obesity, and smoking (Supplemental 5). There was no significant publication bias for hypertension (PEgger = 0.468; PBegg = 0.113). Although the Begg's test indicated no significant publication bias for obesity (P = 0.944) and smoking (P = 0.150), the Egger's test suggested potential significant publication bias for obesity (P = 0.007) and smoking (P = 0.051). After adjustment by the trim and fill method, the pooled conclusions were not significantly changed (Supplemental 5).
Discussion
Principal Findings
This comprehensive quantitative meta-analysis assessed 1,984,552 individuals in 40 prospective cohorts across wide individual characteristics. The results suggested the demographic characteristic of old age; pre-existing diseases such as hypertension, CVD history, CKD, DM, metabolic syndrome, hyperglycemia, and obesity; unhealthy lifestyles, including smoking and prolonged sleep time (>7.5 h); and the biochemical parameters of high TG and CRP levels were all associated with increased risk of stroke in Chinese individuals. Only high fruit-rich diet intake could decrease the risk of stroke. Subgroup analysis suggested the RRs of hypertension and sleep behavior disorder were high in HS, while that of obesity was high in IS. The protective effect of fruit-rich diet was stronger in HS compared with IS. It was also found that the cumulative RRs of hypertension and obesity in HS decreased with increasing inclusion years.
Comparison With Previous Studies
A previous meta-analysis by Wang et al. including only 15 cohorts and 178 case-control studies found hypertension, DM, CVD history, family history of stroke, hyperlipidemia, overweight, and smoking were correlated with high risk of stroke, while PA could reduce the risk of stroke (15). The uncontrolled selection and confounder biases might affect the overall reliability of pooled effect estimates, with both prospective and retrospective observational studies included. In addition, the results regarding single variables in previous meta-analyses are presented in Supplemental 6 (4, 16–32). Although most pooled conclusions in Chinese individuals were consistent with previous meta-analyses, several results should be highlighted. (1) The present study found obesity increased the risk of stroke irrespective of IS or HS, whereas a previous meta-analysis found overweight and obesity increased the risk of stroke with a J-shaped dose-response relationship (4). The potential reason for this discrepancy could be the variable cutoff values for obesity and overweight in individual studies. (2) As shown above, alcohol intake was associated with reduced risk of IS. In comparison, a previous meta-analysis found low-to-moderate alcohol intake was associated with lower risk of IS, whereas heavy alcohol intake increased the risk of both IS and HS (33). A dose-response curve was not generated in this study, because restricted cubic splines with 3 knots at the fixed percentiles of 10, 50, and 90% of distribution were reported in few studies (34). (3) Prolonged sleep time was associated with increased risk of stroke, whereas a previous meta-analysis found both prolonged and short sleep times were correlated with high risk of stroke (21). The potential reason for this difference could be attributed to the small number of included cohorts, and the insufficient statistical power that fails to detect tiny difference.
Implications for Clinicians and Policy Makers
Stratified analyses suggested risk factors for HS and IS differed. Cohort inclusion years could affect the impacts of these risk factors. Several issues should be highlighted based on these findings. (1) As shown above, hypertension was the main risk factor for HS and exerted more effects on HS than on IS. We also found the risk of hypertension decreased for HS while remaining unchanged for IS, and the accumulative RR for hypertension decreased with increasing inclusion years. This may be explained by the current status of hypertension control in China. Hypertension control rates are increasing, coinciding with a rising hypertension prevalence across the nation. According to six national epidemiological investigations, the awareness (26.3 vs. 51.6%), treatment (12.1 vs. 45.8%), and control (2.8% vs. 16.8%) rates for hypertension increased from 1991 to 2015, while hypertension prevalence increased from 5.1% (in 1959) to 7.7% (in 1980), 13.6% (in 1991), 18.8% (in 2002), 25.2% (in 2012), and 27.9% (in 2015) (35). We can therefore infer that hypertension control in China is active but not robust enough. Strategies for hypertension management should be strengthened, and the risk of IS would decrease. (2) Obesity showed a tighter association with the risk of IS compared with HS. Actually, obesity is associated with various ischemic risk factors for stroke, including hypertension, dyslipidemia, DM, obstructive sleep apnea syndrome, and atrial fibrillation. Controlling obesity could decrease the risk of stroke directly and help better manage other risk factors. Similarly, the decreasing adverse impact of obesity on the risk of HS could be partly explained by hypertension, dyslipidemia and DM control strategies implemented in China, while obesity prevalence among Chinese adults has increased substantially with the development of economy (36). These data suggest there is an urgent need to reverse the trend toward obesity. (3) As shown above, fruit-rich diet was a strong protective factor for stroke in China, which remains consistent with previous studies (37, 38). The mechanisms underlying protection from fruits vary by fruit type, including the modulation of molecular events and signaling pathways associated with correcting endothelial dysfunction, reducing disorders in lipid metabolism, anti-hypertension, suppressing platelet function, alleviating I/R injury, inhibiting thrombosis, reducing oxidative stress, and inhibiting inflammatory responses (39). The reasons why fruit-rich diet was associated with lower risk of HS compared with IS in this study deserve further investigation; but fruit-rich diet should be encouraged in our future primary stroke prevention strategy anyway. To meet the challenge of stroke as a major cause of mortality, and long-term physical and cognitive impairment, China launched a nationwide project to promote stroke prevention and control (40). The program has led to a significant improvement in the care for stroke patients. The results of our study suggested similar spectrum of risk factors and preventive strategy in Chinese individuals for stroke when compared with their foreign counterparts, which indicated that clinicians in China can also handle individuals at higher risk of stroke referring to guidelines and evidence from other countries.
Unanswered Questions and Future Research
There has been an increasing interest in novel nontraditional risk factors, some of which are considered to be specifically important in the Chinese population but are not included here due to the limited number of studies taken in. Taking air pollution as an example, the relation between exposure to fine particles and stroke has been reported previously (41). It was shown that air pollution accounts for almost a third of stroke-related disability-adjusted life years, especially in China. Therefore, further prospective studies assessing Chinese individuals are needed, and reducing exposure to air pollution should be one of the top priorities in order to reduce stroke burden. Besides, sleep behavior disorder was a considerable risk factor. However, whether the intervention of sleep behavior disorder could decrease the risk of stroke remains unknown and needs further research.
Strengths and Limitations of Study
The strengths of this comprehensive, quantitative meta-analysis should be highlighted: (1) this study was based on prospective cohort trials, and selection and recall biases could eliminate the concerns of retrospective observational studies; (2) the analysis was based on a large sample size, and the present conclusions were robust than that of any individual study; (3) comprehensive risk factor profiles for the incidence of stroke were provided; and (4) the analysis was stratified by stroke type and cohort inclusion years, which helped explore the potential differences between IS and HS and avoid selection bias.
However, several limitations of this meta-analysis should be acknowledged: (1) the adjusted models were different among the included studies, which might play an important role in the progression of stroke; (2) for certain identified factors, only small numbers of included studies were available, and as a result, the statistical power might not be enough to detect potential associations; (3) this study was based on published articles, and publication bias was therefore inevitable; and (4) the current analysis was based on study-level findings, and individual data were not available, which prevented a more detailed analysis.
Conclusion
We provided a comprehensive updated set of risk factors for stroke in Chinese individuals, which would inspire the design of interventional studies and support future development in guideline or policy for stroke prevention.
Funding
The funder had the following involvement: data collection. The funder was not involved in the study design, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.
Publisher's Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Statements
Data availability statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Author contributions
WX was the study guarantor and designed the review protocol. FS developed the search strategy. WY and FS selected the studies and extracted the data. WX and WY analyzed the data and drafted the manuscript. BW, ML, BS, XH, and FS revised the manuscript for important intellectual content. All authors approved the final version of the manuscript. All authors had access to all the data in the study and take responsibility for the integrity of these data and the accuracy of data analysis.
Acknowledgments
Zhou Yuhao provided support in medical writing and editing. Dr. Qianqian Lin provided valuable comments for manuscript writing.
Conflict of interest
FS was employed by Amgen. This study received funding from Amgen. The funder was involved with data collection. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer W-JT declared a shared affiliation, with no collaboration, with several of the authors WY and WX to the handling editor at the time of the review.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fneur.2022.847304/full#supplementary-material
- BP
blood pressure
- CI
confidence interval
- CKD
chronic kidney disease
- CRP
C-reactive protein
- CVD
cardiovascular disease
- DM
diabetes mellitus
- HR
hazard ratio
- HS
hemorrhagic stroke
- IS
ischemic stroke
- NOS
Newcastle-Ottawa Scale
- OR
odds ratio
- PA
physical activity
- RR
relative risk
- TG
triglycerides.
Abbreviations
References
1.
GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet. (2020) 396:1204–22. 10.1016/S0140-6736(20)30925-9
2.
KrishnamurthiRVIkedaTFeiginVL. Global, Regional and Country-Specific Burden of Ischaemic Stroke, Intracerebral Haemorrhage and Subarachnoid Haemorrhage: a systematic analysis of the Global Burden of Disease Study 2017. Neuroepidemiology. (2020) 54:171–9. 10.1159/000506396
3.
HackshawAMorrisJKBonifaceSTangJLMilenkovicD. Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports. BMJ. (2018) 360:j5855. 10.1136/bmj.j5855
4.
LiuXZhangDLiuYSunXHouYWangBet al. A J-Shaped Relation of Bmi and stroke: systematic review and dose-response meta-analysis of 4.43 million participants. Nutr Metab Cardiovasc Dis. (2018) 28:1092–9. 10.1016/j.numecd.2018.07.004
5.
FengQFanSWuYZhouDZhaoRLiuMet al. Adherence to the dietary approaches to stop hypertension diet and risk of stroke: a meta-analysis of prospective studies. Medicine. (2018) 97:e12450. 10.1097/MD.0000000000012450
6.
GBD 2016 Stroke Collaborators. Global, Regional, and National Burden of Stroke, 1990-2016: a Systematic Analysis for the Global Burden of Disease Study 2016. Lancet Neurol. (2019) 18:439–58. 10.1016/S1474-4422(19)30034-1
7.
TsaiCFThomasBSudlowCL. Epidemiology of stroke and its subtypes in Chinese Vs white populations: a systematic review. Neurology. (2013) 81:264–72. 10.1212/WNL.0b013e31829bfde3
8.
MoherDLiberatiATetzlaffJAltmanDGGroupP. Preferred reporting items for systematic reviews and meta-analyses: the Prisma statement. PLoS Med. (2009) 6:e1000097. 10.1371/journal.pmed.1000097
9.
WellsGSheaBO'ConnellD. The Newcastle-Ottawa Scale (Nos) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. Ottawa, ON: Ottawa Hospital Research Institute (2009). Available online at: http://Www.Ohri.Ca/Programs/Clinical_Epidemiology~/Oxford.Htm
10.
AdesAELuGHigginsJP. The interpretation of random-effects meta-analysis in decision models. Med Dec Mak. (2005) 25:646–54. 10.1177/0272989X05282643
11.
DeeksJHigginsJAltmanD. Analyzing data and undertaking meta-analyses. In: HigginsJGreenS, editors. Cochrane Handbook for Systematic Reviews of Interventions 501. Oxford: The Cochrane Collaboration (2008).
12.
TobiasA. Assessing the influence of a single study in meta-analysis. Stata Tech Bull. (1999) 47:15–7.
13.
AltmanDGBlandJM. Interaction revisited: the difference between two estimates. BMJ. (2003) 326:219. 10.1136/bmj.326.7382.219
14.
EggerMDavey SmithGSchneiderMMinderC. Bias in meta-analysis detected by a simple, graphical test. BMJ. (1997) 315:629–34. 10.1136/bmj.315.7109.629
15.
WangJWenXLiWLiXWangYLuW. Risk Factors for Stroke in the Chinese population: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis. (2017) 26:509–17. 10.1016/j.jstrokecerebrovasdis.2016.12.002
16.
MassonPWebsterACHongMTurnerRLindleyRICraigJC. Chronic kidney disease and the risk of stroke: a systematic review and meta-analysis. Nephrol Dialysis Transpl. (2015) 30:1162–9. 10.1093/ndt/gfv009
17.
PetersSAHuxleyRRWoodwardM. Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775,385 individuals and 12,539 strokes. Lancet. (2014) 383:1973–80. 10.1016/S0140-6736(14)60040-4
18.
ZhangYHuGYuanZChenL. Glycosylated hemoglobin in relationship to cardiovascular outcomes and death in patients with type 2 diabetes: a systematic review and meta-analysis. PLoS ONE. (2012) 7:e42551. 10.1371/journal.pone.0042551
19.
HeJKlagMJWuZWheltonPK. Stroke in the People's Republic of China. Ii. Meta-Analysis of Hypertension and Risk of Stroke. Stroke. (1995) 26:2228–32. 10.1161/01.STR.26.12.2222
20.
LiXLiXLinHFuXLinWLiMet al. Metabolic syndrome and stroke: a meta-analysis of prospective cohort studies. J Clin Neurosci. (2017) 40:34–8. 10.1016/j.jocn.2017.01.018
21.
YinJJinXShanZLiSHuangHLiPet al. Relationship of sleep duration with all-cause mortality and cardiovascular events: a systematic review and dose-response meta-analysis of prospective cohort studies. J Am Heart Assoc. (2017) 6:47. 10.1161/JAHA.117.005947
22.
PanBJinXJunLQiuSZhengQPanM. The relationship between smoking and stroke: a meta-analysis. Medicine. (2019) 98:e14872. 10.1097/MD.0000000000014872
23.
XieLWuWChenJTuJZhouJQiXet al. Cholesterol levels and hemorrhagic stroke risk in East Asian Versus Non-East Asian Populations: a systematic review and meta-analysis. Neurologist. (2017) 22:107–15. 10.1097/NRL.0000000000000126
24.
LabreucheJDeplanqueDTouboulPJBruckertEAmarencoP. Association between change in plasma triglyceride levels and risk of stroke and carotid atherosclerosis: systematic review and meta-regression analysis. Atherosclerosis. (2010) 212:9–15. 10.1016/j.atherosclerosis.2010.02.011
25.
HuxleyRRBarziFLamTHCzernichowSFangXWelbornTet al. Isolated low levels of high-density lipoprotein cholesterol are associated with an increased risk of coronary heart disease: an individual participant data meta-analysis of 23 studies in the Asia-Pacific Region. Circulation. (2011) 124:2056–64. 10.1161/CIRCULATIONAHA.111.028373
26.
LpPLASCThompsonAGaoPOrfeiLWatsonSDi AngelantonioEet al. Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. Lancet. (2010) 375:1536–44. 10.1016/S0140-6736(10)60319-4
27.
OdutayoAWongCXHsiaoAJHopewellSAltmanDGEmdinCA. Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ. (2016) 354:i4482. 10.1136/bmj.i4482
28.
HeYLiYChenYFengLNieZ. Homocysteine level and risk of different stroke types: a meta-analysis of prospective observational studies. Nutr Metab Cardiovasc Dis. (2014) 24:1158–65. 10.1016/j.numecd.2014.05.011
29.
AuneDSenAo'HartaighBJanszkyIRomundstadPRTonstadSet al. Resting heart rate and the risk of cardiovascular disease, total cancer, and all-cause mortality - a systematic review and dose-response meta-analysis of prospective studies. Nutr Metab Cardiovasc Dis. (2017) 27:504–17. 10.1016/j.numecd.2017.04.004
30.
HeFJNowsonCAMacGregorGA. Fruit and vegetable consumption and stroke: meta-analysis of cohort studies. Lancet. (2006) 367:320–6. 10.1016/S0140-6736(06)68069-0
31.
KimKHyeonJLeeSAKwonSOLeeHKeumNet al. Role of total, red, processed, and white meat consumption in stroke incidence and mortality: a systematic review and meta-analysis of prospective cohort studies. J Am Heart Assoc. (2017) 6:83. 10.1161/JAHA.117.005983
32.
ZhongCZhongXXuTXuTZhangY. Sex-specific relationship between serum uric acid and risk of stroke: a dose-response meta-analysis of prospective studies. J Am Heart Assoc. (2017) 6:42. 10.1161/JAHA.116.005042
33.
LarssonSCWallinAWolkAMarkusHS. Differing association of alcohol consumption with different stroke types: a systematic review and meta-analysis. BMC Med. (2016) 14:178. 10.1186/s12916-016-0721-4
34.
OrsiniNBelloccoR. Generalized least squares for trend estimation of summarized dose-response data. Stata J. (2006) 6:40–57. 10.1177/1536867X0600600103
35.
Writing Group of 2018 Chinese Guidelines for the Management of Hypertension, Chinese Hypertension League, Chinese Society of Cardiology. 2018 Chinese guidelines for the management of hypertension. Chin J Cardiovasc Med. (2019) 1:24–56.
36.
MaSXiBYangLSunJZhaoMBovetP. Trends in the prevalence of overweight, obesity, and abdominal obesity among Chinese adults between 1993 and 2015. Int J Obes. (2020) 45: 427–37. 10.1038/s41366-020-00698-x
37.
HuDHuangJWangYZhangDQuY. Fruits and vegetables consumption and risk of stroke: a meta-analysis of prospective cohort studies. Stroke. (2014) 45:1613–9. 10.1161/STROKEAHA.114.004836
38.
WangXOuyangYLiuJZhuMZhaoGBaoWet al. Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies. BMJ. (2014) 349:g4490. 10.1136/bmj.g4490
39.
ZhaoCNMengXLiYLiSLiuQTangGYet al. Fruits for prevention and treatment of cardiovascular diseases. Nutrients. (2017) 9:598. 10.3390/nu9060598
40.
ChaoBHYanFHuaYLiuJMYangYJiXMet al. Stroke prevention and control system in China: Csppc-stroke program. Int J Stroke. (2021) 16:265–72. 10.1177/1747493020913557
41.
BrookRDSunZBrookJRZhaoXRuanYYanJet al. Extreme air pollution conditions adversely affect blood pressure and insulin resistance: the air pollution and cardiometabolic disease study. Hypertension. (2016) 67:77–85. 10.1161/HYPERTENSIONAHA.115.06237
Summary
Keywords
stroke, risk factor, primary prevention, Chinese, meta–analysis
Citation
Yuan W, Wu B, Lou M, Song B, Han X, Sheng F and Xu W (2022) Identification of Risk Factors for Stroke in China: A Meta-Analysis of Prospective Cohort Studies. Front. Neurol. 13:847304. doi: 10.3389/fneur.2022.847304
Received
08 January 2022
Accepted
21 February 2022
Published
18 March 2022
Volume
13 - 2022
Edited by
Gary Kui Kai Lau, The University of Hong Kong, Hong Kong SAR, China
Reviewed by
Juhi Aggarwal, Santosh Medical College, India; Wen-Jun Tu, Chinese Academy of Medical Sciences and Peking Union Medical College, China; Paulina Correa, University of Chile, Chile
Updates
Copyright
© 2022 Yuan, Wu, Lou, Song, Han, Sheng and Xu.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Weihai Xu xuwhpumch@qq.com
This article was submitted to Stroke, a section of the journal Frontiers in Neurology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.